Newspaper Publication of Unaudited Financial Result for the quarter ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Limited has submitted copies of its unaudited financial results for the quarter ended December 31, 2025, as published in Active Times (English) and Mumbai Lakshadeep (Marathi) newspapers on February 11, 2026. On a consolidated basis, the company swung to a net loss of Rs 63.18 lakhs in Q3 FY26, compared to a profit of Rs 178.93 lakhs in the same quarter last year, while total income from operations dropped sharply to Rs 4,080.99 lakhs from Rs 9,310.19 lakhs in the previous quarter (Q2 FY26). On a standalone basis, the company reported a net profit after tax of Rs 75.64 lakhs in Q3 FY26 versus Rs 313.15 lakhs in Q3 FY25, with total income falling to Rs 743.2 lakhs. The filing is submitted under SEBI LODR Regulations 30 and 47, and is purely a regulatory newspaper publication requirement; the detailed results were already filed with the stock exchange.
The sharp sequential decline in both income and profitability — especially the consolidated swing into losses — may concern shareholders, though the standalone entity remained marginally profitable. As this is only a newspaper publication of results already disclosed, no new information is being announced and no immediate stock price reaction is expected.